We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$4.04B
AUM Growth
+$106M
Cap. Flow
+$157M
Cap. Flow %
3.9%
Top 10 Hldgs %
19.27%
Holding
766
New
131
Increased
235
Reduced
189
Closed
186

Top Buys

Rank Stock Value
1
BBH icon
VanEck Biotech ETF
BBH
+$134M
2
AMGN icon
Amgen
AMGN
+$27M
3
WMB icon
Williams Companies
WMB
+$22.5M
4
XOM icon
ExxonMobil
XOM
+$14.7M
5
AES icon
AES
AES
+$13.6M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$24.1M
2
CME icon
CME Group
CME
+$22.7M
3
CXT icon
Crane NXT
CXT
+$13.5M
4
AFG icon
American Financial Group
AFG
+$11.8M
5
VZ icon
Verizon
VZ
+$8.71M

Sector Composition

Rank Sector Weight
1 Financials 18.44%
2 Technology 13.83%
3 Industrials 11.98%
4 Healthcare 11.68%
5 Consumer Staples 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMO
701
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-1,023
Closed -$222K
VIA
702
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
-4,386
Closed -$350K
SALM
703
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
-83,283
Closed -$620K
SRT
704
DELISTED
Startek Inc.
SRT
-28,564
Closed -$248K
GHL
705
DELISTED
Greenhill & Co., Inc.
GHL
-46,488
Closed -$1.36M
VMW
706
DELISTED
VMware, Inc
VMW
-2,754
Closed -$254K
NUVA
707
DELISTED
NuVasive, Inc.
NUVA
-15,342
Closed -$1.15M
CSII
708
DELISTED
Cardiovascular Systems, Inc.
CSII
-7,250
Closed -$205K
LCI
709
DELISTED
Lannett Company, Inc.
LCI
-2,301
Closed -$206K
RSX
710
DELISTED
VanEck Russia ETF
RSX
-34,579
Closed -$715K
ZEN
711
DELISTED
ZENDESK INC
ZEN
-55,484
Closed -$1.56M
PZN
712
DELISTED
Pzena Investment Management, Inc. Class A
PZN
-54,901
Closed -$540K
NP
713
DELISTED
Neenah, Inc. Common Stock
NP
-23,926
Closed -$1.79M
DISCK
714
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-7,561
Closed -$214K
COR
715
DELISTED
Coresite Realty Corporation
COR
-2,868
Closed -$258K
DSPG
716
DELISTED
DSP Group Inc
DSPG
-65,783
Closed -$789K
STAY
717
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
-25,866
Closed -$412K
RP
718
DELISTED
RealPage, Inc.
RP
-49,932
Closed -$1.74M
EGOV
719
DELISTED
NIC Inc
EGOV
-10,968
Closed -$222K
EV
720
DELISTED
Eaton Vance Corp.
EV
-5,777
Closed -$260K
CXO
721
DELISTED
CONCHO RESOURCES INC.
CXO
-2,693
Closed -$346K
FRAN
722
DELISTED
Francesca's Holdings Corporation
FRAN
-879
Closed -$162K
GPOR
723
DELISTED
Gulfport Energy Corp.
GPOR
-20,855
Closed -$359K
AXAS
724
DELISTED
Abraxas Petroleum Corp
AXAS
-3,656
Closed -$148K
RST
725
DELISTED
ROSETTA STONE INC
RST
-41,197
Closed -$402K

Similar funds

Zacks Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Zacks Investment Management held 766 positions worth $4.04B, up 2.7% from $3.93B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Zacks Investment Management deployed $157M of net new capital in Q2 2017, opening 131 new positions and adding to 235 existing holdings. Its largest new stake was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Exelon, an estimated $24.1M trimmed.

  • Zacks Investment Management's largest Q2 2017 buy was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.
  • Zacks Investment Management added most to Amgen in Q2 2017, an estimated $27M increase.
  • Zacks Investment Management's biggest Q2 2017 reduction was Exelon, cutting an estimated $24.1M.
  • Zacks Investment Management fully exited Crane NXT in Q2 2017, selling an estimated $13.5M.
  • Zacks Investment Management's ten largest holdings make up 19% of its $4.04B portfolio in Q2 2017.
  • Zacks Investment Management opened 131 new positions and closed 186 in Q2 2017.
  • Zacks Investment Management's portfolio value rose 2.7% quarter-over-quarter to $4.04B.

Based on Zacks Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.